Clinical Trial Update: Comparing Efficacy and Safety of CinnaGen Biosimilar Growth Hormone (CinnaTropin®) Versus Nordilet in Children With Idiopathic Growth Hormone Deficiency [Phase 3]

View source ↗

Summary

Phase 3 trial comparing biosimilar growth hormone CinnaTropin to Nordilet in children with idiopathic growth hormone deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Growth Hormone Deficiency

Drugs mentioned

• CinnaTropin® (growth hormone biosimilar)
• Nordilet (growth hormone)

Snippet

Sponsor: Cinnagen | Conditions: Idiopathic Growth Hormone Deficiency | Phase 3 | Status: COMPLETED